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Comparison of the effects of ketamine and
fentanyl-midazolam-medetomidine for
sedation of rhesus macaques (Macaca
mulatta)
Henri G. M. J. Bertrand1,2*, Yvette C. Ellen1,3, Stevie O’Keefe1 and Paul A. Flecknell1,4
Abstract
Background: This study assessed the effects of sedation using a combination of fentanyl, midazolam and
medetomidine in comparison to ketamine. Rhesus Macaques (Macaca mulatta), (n = 16, 5 males and 3 females
randomly allocated to each treatment group) received either ketamine (KET) (10 mg.kg−1) or
fentanyl-midazolam-medetomidine (FMM) (10 μg/kg−1; 0.5 mg.kg−1; 20 μg.kg−1) both IM. Oxygen (100 %) was
provided by mask and heart rate, blood pressure, respiratory rate, EtCO2 and depth of sedation were assessed every
5 min for 20 min. After the last time point, FMM monkeys were reversed with atipamezole-naloxone (0.2 mg.kg−1;
10 μg.kg−1). Recovery was scored using clinical scoring scheme. Differences in physiological parameters and quality
of sedation were compared using Area Under the Curve (AUC) method and either Mann-Witney or t-student tests.
Results: Heart rate (beats/min) (Ket = 119 ± 18; FMM = 89 ± 17; p = 0.0066), systolic blood pressure (mmHg) (Ket =
109 ± 10; FMM = 97 ± 10; p = 0.0313), and respiratory rate (breaths/min) (Ket = 39 ± 9; FMM = 29 ± 10; p = 0.0416)
were significantly lower in the FMM group. End-tidal CO2 (mmHg) did not differ between the groups (KET = 33 ± 8;
FMM = 42 ± 11; p = 0.0462). Although some depression of physiological parameters was seen with FMM, the
variables all remained within the normal ranges in both groups. Onset of a sufficient degree of sedation for safe
handling was more rapid with ketamine (KET = 2.9 ± 1.4 min; FMM = 7.9 ± 1.2 min; p = 0.0009), but FMM recovery
was faster (KET = 21.4 ± 13.4 min; FMM = 9.1 ± 3.6 min; p = 0.0379) and of better quality (KET = 1.3 ± 0.9; FMM = 7.4 ±
1.9; p = 0.0009) most probably because of the effectiveness of the reversal agents used.
Conclusion: FMM provides an easily reversible immobilization with a rapid and good recovery quality and may
prove a useful alternative to ketamine.
Keywords: Sedation, Ketamine, Fentanyl, Midazolam, Medetomidine, Recovery macaque
Background
Ketamine, a dissociative anaesthetic, is widely used for the
chemical immobilization of non–human primates (NHPs).
When administered alone it induces a cataleptic state
allowing safe handling as the biting reflex is inhibited [1, 2].
Protective airway reflexes are conserved and voluntary
movement can still occur. Ketamine has some analgesic
activity, allowing minor procedures such as skin suturing to
be undertaken but it is not suitable as a sole agent for more
invasive procedures. Ketamine is an NDMA receptor an-
tagonist, and so should prevent “wind-up” associated with
noxious stimuli [3], but this effect has never been assessed
in NHPs. Several side effects have been described in pri-
mates and other species, including pain on injection, mus-
cular and nerve damage at the site of injection [2, 4–6], and
rarely, seizures [7–10]. Recovery delirium also occurs but
this can be reduced by addition of other agents. Despite
these problems, ketamine is widely used in primates, pri-
marily because of its good safety profile and relative lack of
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depression of the cardiovascular and respiratory systems. For
some procedures, a greater degree of analgesia and muscle
relaxation would be advantageous. Although this can be
achieved by the addition of medetomidine, as in other spe-
cies, recovery is still relatively prolonged even after reversal
of the medetomidine with atipamezole [11]. Replacement of
ketamine with agents that have less prolonged depressant ef-
fects, or are reversible with specific antagonists could there-
fore be advantageous. In human medicine, the combination
of fentanyl and midazolam has been widely used for con-
scious sedation for minor procedures, and at higher dose
rates for surgery [12–15]. Combinations of opioids and ben-
zodiazepines seem to be less effective in Rhesus macaques
[16], however in other species, addition of medetomidine
to these combinations produces fully reversible anaesthe-
sia [17–19] and an initial report suggests this combination
can be used successfully in non-human primates [20].
This study compared the effects of a combination of
fentanyl-midazolam-medetomidine (FMM), followed by
reversal with naloxone and atipamezole, with ketamine
(KET) in rhesus macaques.
Results
Sedation procedure
One female from the KET group started to recover
10 min after administration of the anaesthetic and was
placed in a recovery cage. No physiological parameters
were recorded after this time point, but the recovery
time and the assessment of the recovery quality were
assessed. All of the remaining primates were successfully
immobilized after the administration of either KET or
FMM.
Onset of sedation and recovery times
The onset of a sufficient degree of sedation for safe
handling was significantly shorter in the KET group (2.9
± 1.4 min) than in the FMM group (7.9 ± 1.2 min)(p =
0.0009). Recovery was significantly faster in the FMM
group (9.1 ± 3.6 min) compared to the KET group (21.4
± 13.4 min) (p = 0.0379) (Fig. 1).
Physiological parameters and depth of sedation
The physiological data are summarised in Table 1. Area
under the curves (AUCs) comparisons showed signifi-
cant differences between the two treatment groups. The
heart rate (HR) (p = 0.0066), Respiration rate (RR) (p =
0.0416), systolic blood pressure (BPsyst) (p = 0.0313) and
the end-tidal CO2 (EtCO2) (p = 0.0462) AUCs were sig-
nificantly lower in the FMM group. However, no signifi-
cant difference was found in SpO2 between the two
groups (p > 0.1). The overall degree of sedation over the
20 min procedure was deeper in the FMM group with a
Fig. 1 Onset of sedation and Recovery times in Rhesus macaques receiving ketamine (n = 8) or fentanyl-midazolam-medetomidine (n = 8) Induction
times: Ketamine (KET) 2.9 ± 1.4 min; Fentanyl-midazolam-medetomidine (FMM) 7.9 ± 1.2 min. Recovery times: Ketamine (KET) 21.4 ± 13.4 min;
Fentanyl-midazolam-medetomidine (FMM) 9.1 ± 3.6 min. An asterisk next to a p-value(*p) indicates a significantly differences
Bertrand et al. BMC Veterinary Research  (2016) 12:93 Page 2 of 9
significantly higher score (p = 0.0009) than the KET
group.
Recovery quality
Recovery quality was significantly better in the FMM
group after administration of reversal agents, than in the
ketamine group, as assessed by both the visual analogue
scale (VAS) and the recovery clinical scoring scheme
(RCS) (Fig. 2). The Bland-Altman plots demonstrated a
non-significant bias of 0.1437 and a reasonably good
level of agreement between the two tests (Fig. 3). How-
ever it also showed a non-homogeneous distribution of
the plots that was probably due to the scale difference
between the VAS and the RCS. For the Kappa statistic
analysis, the average of the two observers for each sub-
ject was used. The comparison of recovery group results
Table 1 Physiological parameters recorded over 20 min for each treatment group
Treatment groups p-value
Ketamine Fentanyl-Midazolam-Fentanyl
Time 0
n = 8
5
n = 8
10
n = 8
15
n = 7
20
n = 7
0
n = 8
5
n = 8
10
n = 8
15
n = 8
20
n = 8
HR(beat/min) 134 ± 17 121 ± 18 117 ± 17 110 ± 14 112 ± 18 97 ± 17 90 ± 17 87 ± 18 86 ± 18 85 ± 17 0.0066*
SpO2(%) 98.2 ± 1.0 99.8 ± 0.7 100 ± 0 99.9 ± 0.4 100 ± 0 96.1 ± 7.8 99.6 ± 0.7 99.8 ± 0.5 99.8 ± 0.7 99.6 ± 0.7 0.7254
RR(breaths/min) 36 ± 8 41 ± 8 36 ± 6 40 ± 11 43 ± 11 30 ± 10 28 ± 12 28 ± 11 29 ± 11 29 ± 10 0.0416*
EtCO2(mmHg) 36 ± 8 32 ± 9 32 ± 9 34 ± 9 32 ± 8 39 ± 12 44 ± 11 43 ± 11 44 ± 10 42 ± 10 0.0462*
BPsyst(mmHg) 111 ± 10 111 ± 9 107 ± 9 107 ± 11 108 ± 13 101 ± 9 102 ± 10 97 ± 10 93 ± 9 90 ± 8 0.0313*
SD 12 ± 3 12 ± 2 11 ± 3 11 ± 3 11 ± 4 17 ± 1 18 ± 1 18 ± 1 18 ± 1 18 ± 1 0.0009*
Data are shown as mean ± 1 SD. n represents the number of animals that provide data at the each time point. In the ketamine group one of the primates started
to recover after 10 min of sedation and so recording session was stopped. Areas Under the Curve (AUCs) were calculated for each parameter. The Shapiro-wilk test
showed a normal distribution for Heart Rate (HR), the Respiration Rate (RR), the Systolic Blood Pressure (BPsyst) and the end-tidal CO2 (EtCO2). These AUCs parame-
ters were compared with Student t test. The oxygen saturation (SpO2) and the sedation depth (SD) were compared with the Mann–Whitney U test. An asterisk
next to the p-value indicates a significant statistical difference at α threshold of 5 %
Fig. 2 Recovery quality results in Rhesus macaques receiving ketamine (n = 8) or fentanyl-midazolam-medetomidine (n = 8). The histograms
represent the mean ± 95 % of confidence interval. The results are expressed as mean ± 1 SD. RCS: Ketamine 7 ± 2; Fentanyl-midazolam-
medetomidine 1 ± 1. VAS: Ketamine 6.2 ± 0.8; Fentanyl-midazolam-medetomidine 2.2 ± 0.5. An asterisk next to a p-value(*p) indicates a
significantly differences
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gave a kappa statistic k = 0.662 with a significance of p =
0.01. According to usual interpretation of this result
[21], there was a substantial agreement between the RCS
and VAS.
Discussion
In this study the administration of the FMM com-
bination to rhesus macaques provided a deeper and
more reliable sedation and a better recovery score
than ketamine sedation. The impacts of the two regi-
mens on physiological parameters were consistent
with the known properties and mechanism of action
of the agents used.
High ketamine liposolubility results in rapid bioavailabil-
ity in the central nervous system, resulting in rapid onset of
action [22]. This rapid onset of sedation was observed in
the present study and is similar to that reported in previous
studies [23–25]. Attainment of sedation sufficient for safe
handling was significantly shorter following administration
of ketamine than following FMM, likely due to the different
rates of absorption and distribution of the components of
the combination. The onset of a sufficient degree of sed-
ation to allow safe handling after administration of FMM
observed in this study was longer than that reported
by Votava et al., using a comparable sedation proto-
col [20]. This difference may be due to differences
in the doses of the agents used in the two studies
and the use of hyaluronidase to speed absorption in
Votava study. Recovery time in the FMM group was
significantly shorter than the KET group, very likely
due to the use of specific antagonists to reverse two
of the components used for sedation [26, 27]. We
chose not to administer flumazenil to reverse mid-
azolam, since our experience has shown that mid-
azolam has minimal sedative effects at the dose used
in this species. In this study, because no post-
procedural pain was anticipated, naloxone was used
to reverse the effects of fentanyl. As an alternative,
butorphanol, nalbuphine and buprenorphine have all
been shown to be effective antagonists [28–30]. This
latter approach has the advantage of providing con-
tinued analgesia following reversal of the fentanyl,
because of administration of agents with either k
agonist/μ antagonist activity, or partial μ agonist ac-
tions. A duration of sedation prior to reversal of the
FMM regimen of 20 min was chosen as it repre-
sented the mean time that NHPs can be safely handled
under ketamine sedation [24, 25].
Fig. 3 Bland-Altman plots comparing the quality of recovery in Rhesus macaques receiving ketamine (n = 8) or fentanyl-midazolam-
medetomidine (n = 8). The differences between the scores for each method are plotted against the mean of the two methods. (b) = bias; (b +
1.96 s; b – 1.96 s) = Agreement limits. The shaded lines represent the 95 % confidence intervals of the agreement limits
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Anaesthetic agents decrease central nervous system
activity and the assessment of somatic withdrawal re-
flexes is generally accepted as a means of assessing an-
aesthetic depth [3]. Due to its mechanism of action,
ketamine produces a unique cataleptic state, but one
which can be considered as light sedation based on the
degree of suppression of reflex responses (eg withdrawal
reflexes) [3, 4]. Used alone, ketamine increases muscular
tone in many species [31–33] but this effect is not as
marked in non human primates as in other species [24].
Seizures [7–10] and tissue necrosis [5, 6, 34] can also
occur with ketamine injection. In this study, none of
these complications occurred, however one of the female
primates only remained in lateral recumbency for less
than ten minutes post-injection and this has been ob-
served in other studies [24, 25]. Several hypotheses such
as the variation of the injection site with incomplete
intramuscular administration, individual variability or a
possible acquired tolerance to ketamine [25] can explain
this observation. In this study, the FMM protocol pro-
vided a deeper sedation, comparable to surgical anaes-
thesia. Following completion of this study, we have used
the combination to enable intubation as jaw tone is
markedly reduced and laryngeal reflexes absent. We
have also repaired deep and superficial wounds, which
resulted from fights between cage-mates.
Pulse oximetry was used successfully to assess oxy-
gen saturation, but this technique can be compro-
mised by poor peripheral tissue perfusion [2], such as
can occur when alpha2 agonists are administered.
This was not a problem in the current study. Systolic
blood pressure was measured by a non-invasive oscil-
lometric method. The cuff used to measure the blood
pressure followed the general recommendation that
the cuff width should equal 40 % of the limb circum-
ference [35]. However, this method has been shown
to underestimate systolic and diastolic blood pressures
by between 5 and 20 mmHg depending on the cuff
location [36–38]. Adequacy of ventilation was
assessed using capnography, since this allowed assess-
ment of respiratory rate and pattern and the EtCO2.
The EtCO2 is usually measured at the distal extremity
of the endo-tracheal tube [39, 40], but in the present
study, the EtCO2 was measured in the ventral meatus
of the nose with a sample line linked to a side stream
capnography device. This approach provided a good
waveform and is a technique that could be used rou-
tinely for anaesthetic monitoring in this and other
primate species
However validation of the approach should be per-
formed as published data comparing the technique are
available only in people [41–44].
The significant differences in cardiovascular and re-
spiratory parameters between the sedation protocols in
this study are consistent with the mechanism of action
of the agents used. Ketamine has a minimal impact on
the respiratory system with minimal modification of the
ventilation parameters [3]. The breathing rate observed
and EtCO2 were similar to those described in a previous
study in rhesus macaques but the EtCO2 values recorded
were lower [23, 45]. Ketamine affects the cardiovascular
system by stimulating the sympathetic pathway and in-
creasing circulating catecholamine concentrations [3].
Heart rate and systolic blood pressure effects were also
Fig. 4 Respiration monitoring. A soft lubricated tube was inserted in
the ventral meatus of one of the nostril. The tube was linked to a
side-stream capnograph providing the visualization of a waveform
and end-tidal CO2 value
Table 2 Sedation Depth Scoring System. A higher score
indicates a deeper sedation
Score Movement Palpebral reflex Jaw tone Withdrawal reflex
1 Whole body Blinking +
others movement
increased Normal
2 Limb/foot/
Hand
Blinking Normal Weakly
3 Facial Weak blinking Decreased Delayed
4 Twitching
fingers
Delayed blinking Minimal Only digits
movements
5 No No No No
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consistent with the literature [20, 23, 45, 46]. Due to the
known mechanisms and interactions of the individual
components of the regimen, it was expected the FMM
protocol would have more negative influences on cardio-
vascular and respiratory functions. Midazolam, has seda-
tive and anxiolytic effects but minimal effects on cardio-
respiratory physiology [3, 4], however medetomidine and
fentanyl both depress these system and their effects are
potentiated when they are combined [3]. Although FMM
produced a significant decrease of heart rate, systolic
blood pressure and respiratory function, these values
stayed within acceptable ranges for deeply sedated pri-
mates [1, 3]. There appears to be no previously published
information on the impact of fentanyl-midazolam-
medetomidine on these parameters in macaques, but the
bradycardia noted in this study was similar to that re-
ported by Votava et al. [20]. This combination has varying
effects in other species. In rats, rabbits, Mongolian gerbils
and chinchillas, bradycardia is a consistent finding,
whereas effects on blood pressure varied. In contrast to
other species in which moderate hypotension was re-
ported, rats developed moderate hypertension [17].
The quality of the recovery was assessed by two
methods, a clinical scoring scheme (RCS) and a visual
analogue scale (VAS). The VAS is a subjective single-
item test that in this study was used only to assess the
quality of recovery. VAS assessments are widely used to
assess pain [47], anxiety [48] and other items [49, 50].
Such systems have the advantage of being quick and
easy to perform and also to have good reliability [51].
The clinical scoring scheme used in this study was the
first attempt to construct and use a multiple-item test to
assess recovery in non-human primates. The scale used
was based on the Pediatric Anesthesia Emergence Delir-
ium Scale (PAED) [52, 53]. The items chosen to build
the RCS were based on their abilities to show modifica-
tion in cases of excitation or poor recovery and on the
facility to observe these modifications. The two methods
of assessment demonstrated a strong correlation and a
strong agreement with a non-significant bias. The video
extracts, used for the scoring the quality of recovery, fo-
cused on the period around first attempt to sit. This
period can be considered a critical point in recovery as
excitation, ataxia or hallucination can lead to injury [3,
54]. The study results showed that the recovery quality
was significantly better in the FMM treatment group.
There are several possible explanations for this result.
The use of specific antagonists in the FMM group may
have reversed not only the sedative effects of the three
components but also their side effects [26, 27]. The poor
quality recovery in the ketamine group may have been
the results of ketamine’s dissociative effects [3]. Previous
studies in dogs and cats, using ketamine, did not report
a difference in the quality of recovery compared to other
anaesthetic protocols [55, 56]. However the administra-
tion of ketamine to children and horses prior the end of
anaesthesia resulted in a decrease in the quality of recov-
ery in comparison with the use of α2-agonists, benzodi-
azepine or acepromazine [57, 58].
Conclusion
In conclusion, this study demonstrated the efficacy of
the combination of fentanyl, medetomidine and midazo-
lam to immobilise rhesus macaques. This regimen offers
a potentially useful alternative to ketamine, since specific
antagonists can rapidly reverse it, and this results in a
better quality of recovery.
Methods
Animals
The animals were purpose bred for research in the UK,
and were supplied from the Centre for Macaques to
Newcastle University. Animals were housed in a Home
Table 3 Recovery Clinical Scoring Scheme. System based on 15
points with the principle that a higher score indicates a poorer
recovery
•Eyes
Score 2 1 0 +1 +1
Close Semi-close Open Nystagmus Rubbing
its eyes
•Mouth
Score 3 2 1 0
Vomitting Lips
smacking/
Nausea sign
Hypersalivation Nothing
•Body position
Score 3 2 1 0
Lateral/
ventral
recumbency
Unsuccessful
attempt to
sit
Successful
attempt to sit/
Sit but wobbly
Sit and
stable
•Ataxia
Score 3 2 1 0
Strong Mild Slight Absence
•Environment awareness
Score 2 1 0
No Partially Yes
Total:
/15
Table 4 Recovery quality category
Category VAS RCS
Good 0–3.33 0–5
Moderate 3.34–6.67 6–10
Bad 6.68–10 11–15
VAS visual analogue scale, the range are expressed in cm. RCS recovery clinical
scoring, the ranges are expressed in arbitrary units
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Office (United Kingdom authority) accredited facility
and in compliance with the Animal Scientific Procedure
Act 1986 and the European Directive 2010/63/EU. Rhe-
sus macaques aged from 3 to 10 years and weighing
from 4 to 17.7 kg (n = 16, 10 males and 6 females)
scheduled, in November 2014, for annual health checks
and tuberculosis testing were used in this study. The an-
imals were housed at Comparative Biology Centre (New-
castle University, United Kingdom), in indoor pens with
a solid floor and windows allowing a view on the other
pens and the corridors. A minimum floor area 4.40 m2
was provided for each animal or pair of animals. A
smaller pen with a squeeze-back system was located be-
tween each housing pen. Enrichment devices and sub-
strate for foraging were provided. Animals were
maintained on a light:dark cycle of 12 h:12 h. at a
temperature of 22 °C and with 15 air changes per hour
and a relative humidity of 24 %. Primates were fed with
adapted old world primate diet (Special Diets Service,
Witham, United Kingdom) and received tap water ad
libitum at the time of the study. Forage mix was pro-
vided daily to all animals (LBS Biotechnology, United
Kingdom). Except for two males, all the primates were
paired-housed. The single housing was due to excep-
tional circumstances unrelated to the research protocols.
The primates had not been sedated or anaesthetised dur-
ing the two weeks prior the start of the study.
Sedation protocols
Animals (5 males and 3 females per group) were assigned
randomly to receive either ketamine (KET) or Fentanyl-
Midazolam-Medetomidine (FMM). Animals were fasted at
least 4 h prior to the administration of the sedative agents.
Both sedation protocols were administered by intramuscu-
lar injection in the femoral quadriceps, the femoral biceps
or the gluteal maximus. Ketamine (Ketaset 100 mg/ml So-
lution for Injection, Zoetis, London, United Kingdom) was
administered at the dose of 10 mg.kg−1 [23, 24]. For the
FMM protocol, the dose each drug was determined based
on a pilot study (data not reported here). Fentanyl (Fentanyl
50 micrograms/ml, Martindale Pharmaceutical, Romford,
United Kingdom), midazolam (Midazolam 5 mg/ml,
Hameln pharmaceutical ltd, Gloucester, United Kingdom)
and medetomidine (Domitor 1 mg/ml, Vetoquinol UK ltd,
Buckingham, United Kingdom) were administered at
10 μg.kg−1, 0.5 mg.kg−1 and 20 μg.kg−1, respectively. Due to
the high injection volume 2 injection sites were used. Mid-
azolam and medetomidine were mixed in the same syringe
and injected separately from the fentanyl. When primates
lost their righting reflex and could be safely handled, they
were carried to a room outside of the NHP unit. At the end
of the procedure, primates in the KET group were placed in
a recovery cage and monitored until the return of the right-
ing reflex. In the FMM group, naloxone at 10 μg.kg−1
(Naloxone 400 micrograms/ml Solution for injection/infu-
sion, Hameln pharmaceutical ltd, Gloucester, United King-
dom) and atipamezole (Antisedan 5 mg/ml, Vetoquinol UK
ltd, Buckingham, United Kingdom) at 0.22 mg.kg−1 were
mixed in the same syringe and administered by intramus-
cular injection 20 min after the onset of sedation. Then pri-
mates were transferred to a recovery cage and monitored
until the return of the righting reflex.
Sedation support and monitoring
Physiological parameters and depth of the sedation were
measured every 5 min for 20 min procedure consisting of
venous blood sampling, dental examination, an intradermal
tuberculosis test and a complete physical examination. Ani-
mals were placed in lateral recumbency, covered with a
forced-air warming blanket set at 38 °C (Bair hugger model
505, Augustine Medical, USA) and received 100 % oxygen
supplementation using a face mask (2 to 4 litres per min).
A Vitalogik 4500 monitoring system (Charter-Kontron Ltd,
Milton Keynes, United Kingdom) was used to measure vital
signs. Heart rate (HR) and oxygen saturation (SpO2) were
assessed using an absorbance pulse oxymeter probe placed
on a finger. Blood pressure was assessed using an oscillo-
metric method with a blood pressure cuff (Critikon Dura-
Cuf, GE Healthcare, Hatfield, United Kingdom) appropri-
ate for the size of the animal. The cuff was placed on the
opposite arm to that used for pulse oximetry to record the
blood pressure from the brachial artery. Two measures
were taken at each time point and the mean calculated.
The respiration rate (RR) and the end-tidal CO2 (EtCO2),
were measured by the side stream gas analyser integrated
in the electronic monitoring system. The gas sampling
rate was 50 ml/min. A soft neonatal feeding tube with
1.7 mm of diameter and 38 cm of length (100 % latex-free
Premature Infant Feeding tube, Bard Ltd, Crawley, United
Kingdom) attached to the gas sampling line was lubricated
with lidocaine gel (Anbesol teething gel, Alliance pharma-
ceutical, Chippenham, United Kingdom) and gently ad-
vanced to a depth of 3 cm into the ventral meatus of one
of the nostril (Fig. 4). This operation was repeated at each
time point. The depth of the sedation was assessed by a
clinical scoring scheme adapted from previous publica-
tions (Table 2).
Onset of sedation and recovery times
All of the sedation procedures were videotaped and ana-
lysed at a later date. This enabled blinding of the asses-
sor to the treatment given. The time from administration
of the sedative to the time at which it was considered that
an animal that could be safely handled was recorded. The
recovery time was the time between the end of the 20 min
procedure and the return of the righting reflex. The end
of the procedure was comparable with the injection of the
antidote mix in the FMM group
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Recovery quality assessment
Samples of the video-recording from 2 min before to
2 min after the first attempt to sit were selected and the
quality of recovery assessed by two treatment-blinded
observers using two methods. A recovery clinical scoring
scheme (RCS) consisting of a multiple-item list (Table 3)
and a visual analogue scale (VAS), with a 10 cm line an-
chored with “best possible recovery” and “worst possible
recovery” were used for this assessment. In both scoring
schemes, a high score indicated a poor recovery. The ob-
servers were veterinary technicians with extensive ex-
perience of working with NHPs. Depending on the
numeric result, each recovery was classified using the
categories in Table 4.
Statistical analysis
For the HR, BPSyst, RR, EtCO2, SpO2 and sedation
depth, Area Under the Curves (AUCs) were estimated
using the trapezoidal method [59, 60]. The AUCs nor-
mality distribution was assessed using the Shapiro-Wilk
test. Student’s t test was performed where data were nor-
mally distributed; otherwise the Mann–Whitney U test
was used.
A Mann–Whitney U test was used to compare sed-
ation times and recovery times between the two groups
and the RCS and the VAS sedation recovery scores.
Bland-Altman plots and Kappa statistic methods were
used to assess the agreement between the VAS and RCS
results.
Statistical analyses were performed with SPSS statistic
software (vers. 22, IBM, USA) and Excel (vers. 14.3.0,
Microsoft, USA). A p-value < 0.05 was considered static-
ally significant
Abbreviations
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anesthesia emergence delirium scale; RCS, Recovery Clinical scoring scheme;
RR, respiration rate; VAS, visual analogue scale
Acknowledgement
Authors tank the primate care staff of the comparative Biology Centre and
research assistants of the Institute of Neuroscience for their support in the
accomplishment of this work. HGMJB would like to thanks Dr Matthew C.
Leach for his advices and assistance in data statistical analysis.
Funding
No funding was obtained to support this study
Availability of data and material
The data supporting these research findings are contained within the
manuscript.
Authors’ contribution
HB, YE, SO and PF developed the experimental design of the study,
performed the sedations, prepared and interpreted data, created tables and
figures, drafted and finalized the manuscript. The final version of the
manuscript was read and approved by all authors of this study.
Competing interest
None of the authors of this paper has a financial or personal relationship
with other people or organizations that could inappropriately influence or
bias the content of the paper. The authors declare that they have no
competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The use of these animals for research was authorised by the UK Home Office
(PPL60/4560; PPL70/7976; PPL60/4041; PPl60/4095), and the Newcastle
Animal Welfare and Ethical Review body. The anaesthetic procedures did not
require specific ethical approval as they were undertaken under the
Veterinary Surgeons Act 1966.
Author details
1Comparative Biology Centre, Newcastle University, Framlington Place,
Newcastle Upon Tyne NE2 4HH, UK. 2Faculty of Veterinary Medicine,
University of Liège, Boulevard de Colonster, Liège 4000, Belgium. 3School of
Veterinary Medicine and Science, University of Nottingham, Sutton
Bonington Campus, Loughborough LE12 5RD, UK. 4Institute of Neuroscience,
Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
Received: 20 November 2015 Accepted: 3 June 2016
References
1. Abee CR, Mansfield K, Tardif SD, Morris T. Nonhuman Primates in Biomedical
Research: Biology and Management. London, United Kingdom: Elsevier
Science; 2012.
2. Flecknell P. Laboratory Animal Anaesthesia. 4th ed. Oxford: Elsevier Science; 2015.
3. Grimm KA, Lamont LA, Tranquilli WJ, Greene SA, Robertson SA. Veterinary
Anesthesia and Analgesia. Oxford: Wiley Blackwell; 2015.
4. Plumb DC. Plumb's Veterinary Drug Handbook: Desk Edition. 6th ed. Ames,
IA: Blackwell; 2008.
5. Sun FJ, Wright DE, Pinson DM. Comparison of ketamine versus combination
of ketamine and medetomidine in injectable anesthetic protocols: chemical
immobilization in macaques and tissue reaction in rats. Contemp Top Lab
Anim Sci. 2003;42:32–7.
6. Carrier CA, Donnelly KB. Post-injection sciatic neuropathy in a cynomolgus
macaque (Macaca fascicularis). J Med Primatol. 2013;43:52–4.
7. Adami C, Spadavecchia C, Casoni D. Seizure activity occurring in two dogs
after S-ketamine-induction. Schweiz Arch Tierheilkd. 2013;155:569–72.
8. Celesia GG, Chen R-C. Effects of Ketamine on EEG activity in cats and
monkeys. Electroencephalogr Clin Neurophysiol. 1974;37:345–53.
9. Christe KL, Lee UJ, Lemoy M-J, Havton LA. Generalized Seizure Activity in an
Adult Rhesus Macaque (Macaca mulatta) during Ketamine Anesthesia and
Urodynamic Studies. Comp Med. 2013;63:445–7.
10. Gourie-Devi M, Cherian L, Shankar SK. Seizures in cats induced by ketamine
hydrochloride anaesthesia–a preliminary report. Indian J Med Res. 1983;77:525–8.
11. Baker NJ, Schofield JC, Caswell MD, McLellan AD. Effects of Early
Atipamezole Reversal of Medetomidine–Ketamine Anesthesia in Mice. J Am
Assoc Lab Anim Sci. 2011;50:916–20.
12. Cevik E, Bilgic S, Kilic E, Cinar O, Hasman H, Acar AY, Eroglu M. Comparison of
ketamine–low-dose midozolam with midazolam-fentanyl for orthopedic
emergencies: a double-blind randomized trial. Am J Emerg Med. 2013;31:108–13.
13. Mamula P, Markowitz JE, Neiswender K, Zimmerman A, Wood S, Garofolo M,
Nieberle M, Trautwein A, Lombardi S, Sargent-Harkins L, Lachewitz G, Farace
L, Morgan V, Puma A, Cook-Sather SD, Liacouras CA. Safety of intravenous
midazolam and fentanyl for pediatric GI endoscopy: prospective study of
1578 endoscopies. Gastrointest Endosc. 2007;65:203–10.
14. McQueen A, Wright RO, Kido MM, Kaye E, Krauss B. Procedural Sedation and
Analgesia Outcomes in Children After Discharge From the Emergency
Department: Ketamine Versus Fentanyl/Midazolam. Ann Emerg Med. 2009;
54:191–197.e4.
15. Milić M, Goranović T, Knežević P. Complications of sevoflurane–fentanyl versus
midazolam–fentanyl anesthesia in pediatric cleft lip and palate surgery: a
randomized comparison study. Int J Oral Maxillofac Surg. 2010;39:5–9.
Bertrand et al. BMC Veterinary Research  (2016) 12:93 Page 8 of 9
16. Gerak LR, Brandt MR, France CP. Studies on benzodiazepines and opioids
administered alone andin combination in rhesus monkeys: ventilation and
drug discrimination. Psychopharmacology (Berl). 1998;137:164–74.
17. Albrecht M, Henke J, Tacke S, Markert M, Guth B. Effects of isoflurane,
ketamine-xylazine and a combination of medetomidine, midazolam and
fentanyl on physiological variables continuously measured by telemetry in
Wistar rats. BMC Vet Res. 2014;10:1–14.
18. Albrecht M. Influence of repeated anaesthesia on physiological parameters
in male Wistar rats: a telemetricstudy about isoflurane, ketamine-xylazine
and a combination of medetomidine, midazolam and fentanyl. BMC Vet
Res. 2014;10:1–15.
19. Rahmanian-Schwarz A, Held M, Knoeller T, Amr A, Schaller H-E, Jaminet P.
The Effect of Repetitive Intraperitoneal Anesthesia by Application of
Fentanyl-Medetomidine and Midazolam in Laboratory Rats. J Invest Surg.
2012;25:123–6.
20. Votava M, Hess L, Schreiberová J, Málek J, Štein K. Short term pharmacological
immobilization in macaque monkeys. Vet Anaesth Analg. 2011;38:490–3.
21. Viera AJ, Garrett JM. Understanding Interobserver Agreement: The Kappa
Statistic. Fam Med. 2005;37:360–3.
22. Kohn DF, Wixson SK, White WJ, Benson GJ. Anesthesia and Analgesia in
Laboratory Animals. New York: Elsevier Science; 1997.
23. Lee VK, Flynt KS, Haag LM, Taylor DK. Comparison of the Effects of
Ketamine, Ketamine–Medetomidine, and Ketamine– Midazolam on
Physiologic Parameters and Anesthesia-Induced Stress in Rhesus (Macaca
mulatta) and Cynomolgus (Macaca fascicularis) Macaques. J Am Assoc Lab
Anim Sci. 2010;49:57–63.
24. Naccarato EF, Hunter WS. Anaesthetic effects of various ratios of ketamine
and xylazine in rhesus monkeys (Macaca mulatta). Lab Anim. 1979;13:317–9.
25. Settle TL, Rico PJ, Lugo-Roman LA. The effect of daily repeated sedation
using ketamine or ketamine combined with medetomidine on physiology
and anesthetic characteristics in Rhesus Macaques. J Med Primatol. 2010;39:
50–7.
26. Dahan A, Aarts L, Smith TW. Incidence, Reversal, and Prevention of Opioid-
induced Respiratory Depression. Anesthesiology. 2010;112:226–38.
27. Sinclair MD. A review of the physiological effects of α2-agonists related to
the clinical use of medetomidine in small animal practice. Can Vet J. 2003;
44:885–97.
28. Flecknell PA, Liles JH, Wootton R. Reversal of fentanyl/fluanisone
neuroleptanalgesia in the rabbit using mixed agonist/antagonist opioids.
Lab Anim. 1989;23:147–55.
29. Hu C, Flecknell PA, Liles JH. Fentanyl and medetomidine anaesthesia in the
rat and its reversal using atipamazole and either nalbuphine or
butorphanol. Laboratory Animals. 1992;26:15–22.
30. Latasch L, Probst S, Dudziak R. Reversal by Nalbuphine of Respiratory
Depression Caused by Fentanyl. Anesth Analg. 1984;63:814–6.
31. Haskins SC, Farver TB, Patz JD. Ketamine in dogs. Am J Vet Res. 1985;46:
1855–60.
32. Moreland AF, Glaser C. Evaluation of ketamine, ketamine-xylazine and
ketamine-diazepam anesthesia in the ferret. Lab Anim Sci. 1985;35:287–90.
33. Nowrouzian I, Schels HF, Ghodsian I, Karimi H. Evaluation of the anaesthetic
properties of ketamine and a ketamine/xylazine/atropine combination in
sheep. Vet Rec. 1981;108:354–6.
34. Wellington D, Mikaelian I, Singer L. Comparison of Ketamine–Xylazine and
Ketamine–Dexmedetomidine Anesthesia and Intraperitoneal Tolerance in
Rats. J Am Assoc Lab Anim Sci. 2013;52:481–7.
35. Clark JA, Lieh-Lai MW, Sarnaik A, Mattoo TK. Discrepancies Between Direct
and Indirect Blood Pressure Measurements Using Various Recommendations
for Arm Cuff Selection. Pediatrics. 2002;11:920–3.
36. Chester AE, Dorr AE, Lund KR, Wood LD. Noninvasive measurement of
blood pressure in conscious cynomolgus monkeys. Fundam Appl Toxicol.
1992;19:64–8.
37. Wiester MJ, Iltis R. Diastolic and systolic blood pressure measurements in
monkeys determined by a noninvasive tail-cuff technique. J Lab Clin Med.
1976;87:354–61.
38. Yeung KR, Lind JM, Heffernan SJ, Sunderland N, Hennessy A, Makris A.
Comparison of indirect and direct blood pressure measurements in
baboons during ketamine anaesthesia. J Med Primatol. 2014;43:217–24.
39. Belenkiy S, Ivey KM, Batchinsky AI, Langer T, Necsoiu C, Baker W, Salinas J,
Cancio LC. Noninvasive Carbon Dioxide Monitoring in a Porcine Model of
Acute Lung Injury Due to Smoke Inhalation and Burns. Shock. 2013;39:
495–500.
40. Fierstra J, Winter JD, Machina M, Lukovic J, Duffin J, Kassner A, Fisher JA.
Non-invasive accurate measurement of arterial PCO2 in a pediatric animal
model. J Clin Monit Comput. 2013;27:147–55.
41. Manifold CA, Davids N, Villers LC, Wampler DA. Capnography for the
nonintubated patient in the emergency setting. J Emerg Med. 2013;45:626–32.
42. Fukuda K, Tatsuya I, Kaneko Y. Is Measurement of end-tidal CO2 through a
nasal cannula reliable? Anesth Prog. 1997;1–4.
43. Agus MS, Alexander JL, Mantell PA. Continuous non-invasive end-tidal CO2
monitoring in pediatric inpatients with diabetic ketoacidosis. Pediatric
Diabetes. 2006;7:1–5.
44. Yanagidate F, Dohi S. Modified nasal cannula for simultaneous oxygen
delivery and end-tidal CO2 monitoring during spontaneous breathing. Eur J
Anaesthesiol. 2006;23:257–60.
45. Winterborn AN, Bates WA, Feng C, Wyatt JD. The efficacy of orally dosed
ketamine and ketamine/medetomidine compared with intramuscular
ketamine in rhesus macaques (Macaca mulatta) and the effects of dosing
route on haematological stress markers. J Med Primatol. 2008;37:116–27.
46. Young SS, Schilling AM, Skeans S, Ritacco G. Short duration anaesthesia with
medetomidine and ketamine in cynomolgus monkeys. Lab Anim. 1999;33:162–8.
47. Myrvik MP, Drendel AL, Brandow AM, Yan K, Hoffmann RG, Panepinto JA. A
Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease:
Visual Analog Scale Versus Numeric Rating Scale. J Pediatr Hematol Oncol.
2015;37:190–4.
48. Abend R, Dan O, Maoz K, Raz S, Bar-Haim Y. Reliability, validity and
sensitivity of a computerized visual analog scale measuring state anxiety. J
Behav Ther Exp Psychiatry. 2014;45:447–53.
49. Rausch M, Zehetleitner M. Comparison between a visual analogue scale and
a four point scale as measures of conscious experience of motion.
Conscious Cogn. 2014;28:126–40.
50. Wehby G, Naderi H, Robbins J, Ansley T, Damiano P. Comparing the Visual
Analogue Scale and the Pediatric Quality of Life Inventory for Measuring
Health-Related Quality of Life in Children with Oral Clefts. IJERPH. 2014;11:
4280–91.
51. Maxwell C. Sensitivity and Accuracy of the Visual Analogue Scale: A Psycho-
Physical Classroom Experiment. Br J Clin Pharmac. 1978;6:15–24.
52. Janssen NJJF, Tan EYL, Staal M, Janssen EPCJ, Leroy PLJM, Lousberg R, van
Os J, Schieveld JNM. On the utility of diagnostic instruments for pediatric
delirium in critical illness: an evaluation of the Pediatric Anesthesia
Emergence Delirium Scale, the Delirium Rating Scale 88, and the Delirium
Rating Scale-Revised R-98. Intensive Care Med. 2011;37:1331–7.
53. Sikich N, Lerman J. Development and Psychometric Evaluation of the Pediatric
Anesthesia Emergence Delirium Scale. Anesthesiology. 2004;100:1138–45.
54. Costi D, Ahmed S, Stephens K, Strickland P, Ellwood J, Larsson JN, et al.
Effects of sevoflurane versus other general anaesthesia on emergence
agitation in children (Review). The Cochrane Library. 2014;1–212.
55. Freitas GC, da Cunha MG MCM, Gomes K, da Cunha JP MCM, Togni M, Pippi
NL, Carregaro AB. Acid–base and biochemical stabilization and quality of
recovery in male cats with urethral obstruction and anesthetized with
propofol or a combination of ketamine and diazepam. Can J Vet Res. 2012;
76:201–8.
56. Kennedy MJ, Smith LJ. A comparison of cardiopulmonary function, recovery
quality, and total dosages required for induction and total intravenous
anesthesia with propofol versusa propofol-ketamine combination in healthy
Beagle dogs. Vet Anaesth Analg. 2014;42:350–9.
57. Chen J, Li W, Hu X, Wang D. Emergence agitation after cataract surgery in
children: a comparison of midazolam, propofol and ketamine. Pediatr
Anesth. 2010;20:873–9.
58. Valverde A, Black B, Cribb NC, Hathway A, Daw A. Assessment of unassisted
recovery from repeated general isoflurane anesthesia in horses following
post-anesthetic administration of xylazine or acepromazine or a
combination of xylazine and ketamine. Vet Anaesth Analg. 2012;40:3–12.
59. Bate ST, Clark RA. The Design and Statistical Analysis of Animal
Experiments. Cambridge, United Kingdom: Cambridge University Press;
2014.
60. Liengme B: A Guide to Microsoft Excel 2007 for Scientists and Engineers.
Burlington, MA: Elsevier Science; 2008.
Bertrand et al. BMC Veterinary Research  (2016) 12:93 Page 9 of 9
